M. Wilsey
Président chez SAREPTA THERAPEUTICS, INC.
Fortune : 28 M $ au 30/04/2024
Profil
Fondatrice de Kew, Inc. et de la Coalition for 21st Century Medicine, M. Kathleen Behrens Wilsey occupe actuellement le poste de président du conseil d'administration de Sarepta Therapeutics, Inc. et de président du conseil d'administration de MiMedx Group, Inc. Le Dr Wilsey est également membre du conseil d'administration d'IGM Biosciences, Inc. Auparavant, le Dr Wilsey a été président du conseil et président de la National Venture Capital Association, président et directeur général de Kew, Inc. et directeur général de RS Investment Management Co. LLC, directeur général et associé général chez Robertson Stephens & Co. et directeur des politiques scientifiques, technologiques et économiques au National Research Council. M. Kathleen Behrens Wilsey a obtenu un diplôme de premier cycle et un doctorat de l'Université de Californie, Davis.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/04/2024 | 184 993 ( 0,20% ) | 24 M $ | 30/04/2024 | |
IGM BIOSCIENCES, INC.
1,19% | 29/03/2024 | 400 359 ( 1,19% ) | 3 M $ | 30/04/2024 |
MIMEDX GROUP, INC.
0,11% | 13/06/2023 | 160 972 ( 0,11% ) | 1 M $ | 30/04/2024 |
Postes actifs de M. Wilsey
| Sociétés | Poste | Début |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Président | 16/04/2015 |
| IGM BIOSCIENCES, INC. | Directeur/Membre du Conseil | 31/01/2019 |
| MIMEDX GROUP, INC. | Président | 19/06/2019 |
Anciens postes connus de M. Wilsey
| Sociétés | Poste | Fin |
|---|---|---|
Kew, Inc.
 Kew, Inc. Medical/Nursing ServicesHealth Services Kew, Inc. provides oncology services. It provides multiple services to oncologists to assist in treatment decisions for cancer patients and offers genomic testing for patient tumor samples and genomic information important to diagnostic and treatment decisions that assist physicians and are detailed in cancer-specific Therapeutic Pathways. The company was founded by Richard Bohmer, Viren Mehta, Clayton Matt Christensen, Jeffrey Elton, Mason Freeman, John P. Glaser, H. Robert Horvitz, Bruce Johnson, Kathy Behrens Wilsey and Raju S. Kucherlapat in 2009 and is headquartered in Cambridge, MA. | Directeur Général | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 08/08/2012 |
RS Investment Management Co. LLC
 RS Investment Management Co. LLC Investment ManagersFinance RS Investment Management Co. LLC (also known as RS Investments) is an investment advisor and mutual fund manager headquartered in San Francisco, California. Founded in 1986, the firm was acquired by Victory Capital Management, Inc. from The Guardian Life Insurance Co. of America in July 2016. They operate as an independent franchise within Victory Capital's multi-boutique model. Each of the teams within the RS franchise continues to operate autonomously. RS Investments provides investment advisory services to mutual funds, institutions, private pooled investment vehicles, and high net-worth individuals. | Corporate Officer/Principal | 01/12/2009 |
| President's Council of Advisors on Science & Technology | Corporate Officer/Principal | 01/01/2009 |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Directeur/Membre du Conseil | - |
Formation de M. Wilsey
| University of California, Davis | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| IGM BIOSCIENCES, INC. | Health Technology |
| MIMEDX GROUP, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
| Robertson Stephens & Co. | Finance |
The National Research Council
 The National Research Council Miscellaneous Commercial ServicesCommercial Services The National Research Council provides science, technology and health policy consulting and advice. The company was founded in 1916 and is headquartered in Washington, DC. | Commercial Services |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Commercial Services |
RS Investment Management Co. LLC
RS Investment Management Co. LLC Investment ManagersFinance RS Investment Management Co. LLC (also known as RS Investments) is an investment advisor and mutual fund manager headquartered in San Francisco, California. Founded in 1986, the firm was acquired by Victory Capital Management, Inc. from The Guardian Life Insurance Co. of America in July 2016. They operate as an independent franchise within Victory Capital's multi-boutique model. Each of the teams within the RS franchise continues to operate autonomously. RS Investments provides investment advisory services to mutual funds, institutions, private pooled investment vehicles, and high net-worth individuals. | Finance |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Kew, Inc. provides oncology services. It provides multiple services to oncologists to assist in treatment decisions for cancer patients and offers genomic testing for patient tumor samples and genomic information important to diagnostic and treatment decisions that assist physicians and are detailed in cancer-specific Therapeutic Pathways. The company was founded by Richard Bohmer, Viren Mehta, Clayton Matt Christensen, Jeffrey Elton, Mason Freeman, John P. Glaser, H. Robert Horvitz, Bruce Johnson, Kathy Behrens Wilsey and Raju S. Kucherlapat in 2009 and is headquartered in Cambridge, MA. | Health Services |
| The Coalition for 21st Century Medicine | |
| President's Council of Advisors on Science & Technology | Government |